0001415889-23-004091.txt : 20230303 0001415889-23-004091.hdr.sgml : 20230303 20230303161446 ACCESSION NUMBER: 0001415889-23-004091 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Trencher Daniel CENTRAL INDEX KEY: 0001830122 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 23704119 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 form4-03032023_090316.xml X0306 4 2023-03-01 0001477449 Teladoc Health, Inc. TDOC 0001830122 Trencher Daniel C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 false true false false SVP CORPORATE STRATEGY Common Stock 2023-03-01 4 M 0 4716 A 25124 D Common Stock 2023-03-02 4 S 0 1950 25.362 D 23174 D Common Stock 2023-03-02 4 M 0 1004 A 24178 D Common Stock 2023-03-02 4 M 0 1706 A 25884 D Common Stock 2023-03-02 4 M 0 430 A 26314 D Common Stock 2023-03-02 4 M 0 956 A 27270 D Common Stock 2023-03-02 4 M 0 723 A 27993 D Common Stock 2023-03-02 4 M 0 365 A 28358 D Restricted Stock Units 2023-03-01 4 M 0 4716 0 D Common Stock 4716 9433 D Restricted Stock Units 2023-03-02 4 M 0 1004 0 D Common Stock 1004 0 D Performance Stock Units 2023-03-02 4 M 0 1706 0 D Common Stock 1706 0 D Performance Stock Units 2023-03-02 4 M 0 430 0 D Common Stock 430 0 D Restricted Stock Units 2023-03-02 4 M 0 956 0 D Common Stock 956 956 D Performance Stock Units 2023-03-02 4 M 0 723 0 D Common Stock 723 722 D Performance Stock Units 2023-03-02 4 A 0 729 0 A Common Stock 729 729 D Performance Stock Units 2023-03-02 4 M 0 365 0 D Common Stock 365 364 D Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Performance stock units convert to shares of TDOC common stock on a one-for-one basis. On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 2, 2020, the reporting person was granted 3,012 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. On March 2, 2021, the reporting person earned 5,120 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. On March 2, 2022, the reporting person earned 859 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. On March 2, 2021, the reporting person was granted 2,868 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. On March 2, 2022, the reporting person earned 2,168 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Each performance stock unit represents a contingent right to receive one share of TDOC common stock. Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2022. The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023. On March 2, 2023, the reporting person earned 729 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. /s/ Adam C. Vandervoort, Attorney-in-Fact 2023-03-03